Medical Devices Startups
6,372 companies tagged Medical Devices, with their investors and founders.
VisusNano develops ophthalmic drug delivery products, focusing on treatments for ocular and eye diseases. The company combines expertise in drug delivery, ophthalmic surgery, and clinical trials to create products for eye-care patients.
2 investors
Vitarka Therapeutics develops ENDOPORE, a drug delivery technology designed to transport therapeutic molecules into cells to treat diseases including cancer. The company operates in the biotechnology sector, focusing on solving a key challenge in drug development by enabling treatment targets that previously could not be reached.
2 investors
Vitestro is a Netherlands-based medical robotics company that develops Aletta, an autonomous robotic phlebotomy device for diagnostic blood collection in hospitals and laboratories. The company combines engineering expertise with clinical insights to deliver safe, reliable, and efficient blood collection technology.
2 investors
Vitranu develops biomaterial and biologic technologies for ophthalmic applications, particularly focused on retinal and vitreoretinal diseases. The company brings medical devices and therapeutics to market for eye care professionals and patients.
2 investors
Vittoria develops immunotherapies, specifically CAR T-cell therapies, to treat difficult-to-treat diseases including cancers beyond B-cell types. The company focuses on expanding the scope and efficacy of CAR T-cell treatment for patients with limited therapeutic options.
2 investors
VitVio builds Vetro, a surgical operations platform that uses 3D spatial intelligence and ambient sensing to track perioperative workflows in real time, automatically generate operative notes, identify surgical trays, and write data back to hospital EHR systems like Epic and Cerner. It serves hospitals and operating room teams to improve theatre efficiency, reduce clinician administrative burden, and recover hidden OR capacity.
2 investors
Medivis develops augmented reality and AI technology for surgical navigation and clinical training, giving surgeons real-time imaging to guide procedures and reduce surgical errors. The company serves hospitals and medical centers, with its systems deployed across institutions in the United States.
2 investors
Vivifi Medical develops a minimally invasive device to treat the underlying causes of Benign Prostatic Hyperplasia (BPH) in patients. The company builds urological medical devices and operates with a bi-coastal presence in Houston (Texas Medical Center) and Portland, Oregon.
2 investors
VIVUS is a pharmaceutical company developing and commercializing therapies for patients with serious medical conditions and life-limiting diseases. The company advances innovative treatments through clinical development and commercialization expertise.
2 investors
Voio develops AI tools for radiologists to enhance clinical care and patient outcomes in medical imaging. The company focuses on the healthcare industry where artificial intelligence applications remain underutilized.
2 investors
Vonova develops the Cerebro Platform, a minimally invasive neurovascular system that uses the body's venous system to access the brain, guided by real-time imaging to deliver diagnostic and therapeutic treatments without drilling through the skull. It targets chronic neurological disorders such as chronic subdural hematomas, neuropathic pain, and epilepsy in the medical device sector.
2 investors
Vortex develops compact, operator-independent 3D medical imaging systems using proprietary acoustic algorithms adapted from geophysics techniques. The technology delivers fast, radiation-free volumetric scans for clinicians in hospitals and clinical settings to enable quicker diagnostic decisions.
2 investors
vTv Therapeutics is a biopharmaceutical company developing oral, small molecule drugs for diabetes and other chronic diseases. Its lead candidate, cadisegliatin, is a glucokinase activator in Phase 3 trials for treating type 1 diabetes.
2 investors
Vulcan Augmetics develops upper-limb prosthetic solutions and smart sensor systems for rehabilitation and patient care. The company serves clinics and patients globally, with particular focus on emerging markets and regions with limited access to advanced medical technology.
2 investors
VytlOne provides integrated pharmacy solutions for hospitals, health systems, and employers, including specialty pharmacy services, pharmacy benefits management, and 340B program management. The company serves healthcare providers and payers seeking to optimize pharmacy operations and patient outcomes.
2 investors
Walden Biosciences is a clinical-stage biotech company developing disease-modifying therapies that selectively target the kidney to treat the underlying drivers of kidney disease. Its pipeline aims to change the treatment landscape for patients with degenerative kidney diseases.
2 investors
Watkins-Conti develops YΕni.Fit, a medical device for women's pelvic health that received FDA 510(k) clearance in August 2024 after a national clinical trial conducted by urogynecologists at Stanford, NYU, and Jefferson Health.
2 investors
Wave Therapeutics develops active therapeutic wheelchair cushions and related products that use microprocessor-controlled pumps to prevent pressure injuries in mobility-impaired populations including seniors, veterans, and patients with spinal cord injuries. The company also plans to offer mattress toppers, consumer products for long-haul occupations, and military products, all generating analytics to help anticipate and prevent complications.
2 investors
Wavewise develops brain monitoring technology for brain injury care in healthcare settings. The company serves healthcare professionals and patients, focusing on improving outcomes through medical device innovation.
2 investors
WCG advances clinical trial efficiency and outcomes through research services and advisory support. The company serves the medical research and clinical trial industry.
2 investors
Winter Innovations develops surgical tools for orthopedic procedures, with a focus on improving ligament and tendon repair techniques. The company serves orthopedic surgeons seeking more efficient and reliable stitching solutions.
2 investors
WIVI Vision develops software and customized hardware that assess and train non-strabismic binocular vision dysfunctions using immersive 3D games, gamification, and AI. The medical device is sold to authorized eye care professionals to diagnose and treat visual efficiency problems in children and adults.
2 investors
Woven Orthopedic Technologies develops the Ogmend Implant Enhancement System, a surgical implant designed to improve screw fixation in orthopedic and spine surgery for treating complex fixation scenarios.
2 investors
X-Bolt is a rotationally stable hip fracture fixation implant evaluated in clinical trials for treating unstable femoral fractures. The device demonstrated superior biomechanical performance and lower cut-out rates compared to standard screw fixation in randomized controlled trials.
2 investors